Skip to content

Spect

YC S17 · Inactive · Value-based retinal screening in primary care to prevent blindness.

Competitors

Adjacent

Also from S17 in AI

All of S17

About Spect

Vision Disease cause innumerable cases of preventable blindness globally - 415 million diabetic patients worldwide are susceptible to Diabetic Retinopathy (DR), Glaucoma, and more. Current screening protocols for vision disease require ophthalmologists to manually diagnose patients through visual assessment of the fundus. Given the large number of diabetes patients in various communities, this process is expensive, inefficient, and an undue burden on eye clinics.

YC batch
S17 · Summer 2017
Status, per YC
Inactive
Category
AI
Team size
7
Location
San Francisco, CA, USA; Palo Alto, CA, USA; Remote
Checked
4h ago

YC tags: Digital Health, AI

Spect in S17: 125 companies, 26% AI

Spect: questions

Which YC batch was Spect in?

Spect was in Y Combinator's Summer 2017 batch (S17).

Is Spect still active?

Y Combinator lists Spect as inactive.

Where is Spect based?

Spect lists San Francisco, CA, USA; Palo Alto, CA, USA; Remote as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.